TRIGLAV INVESTMENTS, D.O.O.

Position in DXCM — Dexcom Inc

CIK 2056690 LJUBLJANA, 2A

Position in DXCM

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,245,975

+$84,175 QoQ

Shares Held

18,500

0.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#448

of 966 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TRIGLAV INVESTMENTS, D.O.O. holds $9,857,923 across 5 Medical Devices names. DXCM ranks #5 (12.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDT	Medtronic plc	49,909	$3,904,381
2	ABT	Abbott Laboratories	20,000	$1,814,800
3	EW	Edwards Lifesciences Corp	18,060	$1,633,707
4	BSX	Boston Scientific Corp	29,500	$1,259,060
5	DXCM	Dexcom Inc This page	18,500	$1,245,975

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,245,975	18,500	0.0%	Shares	Sole	2026-08-11
2026-03-31	$1,161,800	18,500	0.0%	Shares	Sole	2026-05-04
2025-12-31	$1,227,845	18,500	0.0%	Shares	Sole	2026-02-10
2025-09-30	$1,244,865	18,500	0.0%	Shares	Sole	2025-11-05
2025-06-30	$1,614,865	18,500	0.0%	Shares	Sole	2025-08-05
2025-03-31	$1,263,365	18,500	0.0%	Shares	Sole	2025-05-13
2024-12-31	$1,438,745	18,500	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.